When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price, from Pharmaceutical companies and payers to HCPs and their patients. The cost of non-adherence alone is US$300 billion per year with $188 billion of US pharma revenue lost.
The rules around healthcare engagement are now being rewritten with connected ecosystems and the ability to link self administered medications to disease management solutions. Technology has the potential to augment patient care, deliver value across the digital health ecosystem and deliver better outcomes for all stakeholders in a more connected future.
Aptar Pharma’s broad range of Digital Healthcare solutions come with trusted experience, empowering patients to take their health into their own hands and deliver value to HCPs, payers and our Pharma partners.
Adam Shain is the Business Development Director for Aptar Pharma’s Digital Healthcare division. Previously he worked in Aptar Pharma’s Injectables, Prescription, and CHC divisions. Prior to working at Aptar Pharma, Adam worked at Promius Pharma, a subsidiary of Dr. Reddy’s Laboratories, where he was instrumental in the development, commercialization, and launch of many of its branded products. He has a M.S. Degree in Biomedical Engineering from NJIT.
Joe Reynolds leads Noble’s Market Insights team and works closely with industry stakeholders to develop high-impact training and onboarding programs to improve patient adherence and outcomes. His experience includes work across multiple routes of administration and therapeutic areas. Joe holds a Bachelor of Science in Business from the University of Central Florida, a Master of Science in Marketing from the University of South Florida and a Master of Science in Pharmacy and Master Certificate in Drug Regulatory Affairs from the University of Florida.
Date: Wednesday, June 2, 2021
Time: 10am ET / 7am PT
Duration: 1 Hour
NOW AVAILABLE ON-DEMAND